Gregory P. Hanson, Chief Financial Officer at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX), bought 3,000 shares at $2.50 ($8K) on 2014-12-16, disclosed to the SEC on 2014-12-17.
Open-market purchase of $8k MBVX by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| MBVX | BUY | 2017-08-02 | $8K | — | Filing → |
| MBVX | SELL | 2017-04-14 | $8K | — | Filing → |
| MBVX | SELL | 2017-04-11 | $2K | — | Filing → |